SALT LAKE CITY, UT--(Marketwired - Aug 15, 2013) - Exlites Holdings International, Inc. (PINKSHEETS: EXHI) announced today that it is in negotiations with China based medical equipment manufacturers regarding a partnership that allows the company to offer high-tech medical equipment to its customers at cost effective prices. Exlites offers the manufacturer's products on its online platform at affordable prices to its clients and the Chinese manufacturers have an avenue to offer their cutting-edge products to a large new consumer base.

According to research reports in the medical device industry, China, India, Brazil, Russia, and Eastern Europe are expected to offer the most growth opportunities for industry growth in 2013. The Medical Device Industry ranks among the top-five industries for 2013.

This ambitious goal of partnering with international product manufacturers, will complement other Exlites efforts, and offers new cutting-edge products to its client base at affordable prices. Management has set a goal to triple the company's current product offering in the next few weeks. Building on the initial success of the Exlites website launch, the company is looking to partner with select manufacturers overseas to lower costs for its clients and at the same time increase margins for the company's bottom line.
Kevin Johnson, Director, Business Development, said, "We are witnessing unprecedented demands for medical equipment both from individual clients and medical facilities. By partnering with international manufacturers, Exlites can assure that it offers high-quality high-technology medical equipment to customers at a cost effective price point."

Exlites was incorporated in the U.S., and until recently, was mainly engaged in business in Japan. Recently, management determined that it was in the Company's best interest to enter the larger U.S. medical equipment market and take advantage of its relationships. Exlites' business model is unique in that the Company strives to provide assistance and resources to certain medical equipment manufacturers, many of whom are overseas. By partnering with these medical equipment companies, Exlites can obtain better pricing for the best quality products for its customers. Exlites' business plan includes assisting manufacturers to obtain FDA registration and approval.

SALT LAKE CITY, UT--(Marketwired - Aug 13, 2013) - Exlites Holdings International, Inc. (PINKSHEETS: EXHI) announced the launch of its new online ecommerce site today. The new site will be a convenient way for patients as well as medical professionals to order the necessary medical equipment in a timely and cost effective manner.

"In today's fast paced environment people are very busy and look for a convenient solution for their medical equipment needs. The ability for patients and medical professionals to order the products and medical equipment they need from the convenience of a personal computer in extremely valuable," said Keith Anderson, Exlites Holdings, Marketing and Development.

Exlites website is launching with core products that research has shown to be in great demand and affordably priced. The Company seeks to source innovative medical products for its customers. The Company is leveraging its relationships in China, Taiwan and Japan to provide its customers the most cost effective products designed with cutting-edge technology. The Company's products range from the following categories:

ResMed Corp Mirage Micro™ Nasal CPAP Mask
The ResMed Mirage Micro™ is the latest generation of nasal CPAP mask. The ResMed Mirage Micro nasal CPAP mask provides a personalized fit, seal and comfort for more CPAP and BiPAP users than the original ResMed Ultra Mirage.

Intermittent Catheters
Intermittent Catheters for self catheterization is a sterile process of draining urine from the bladder when normal draining is not possible. Proper Intermittent Catheter use will reduce the threat of urinary tract infections and damage to the kidneys.

Sting-free Protective Barrier Wipes
Sting Free Quick-drying wipes protect skin from adhesive stripping, body fluids and incontinence, without stinging. Using wipes forms a transparent, protective barrier between skin and moisture for 72 hours.

Alternate Site Lancing Device
Lancing Device is a small, spring-loaded pen device that is used with a standard lancet to obtain a capillary blood sample.
With great pricing, same day shipping, Exlites has the professional medical equipment healthcare facilities as well as individual patients use daily.

Exlites was incorporated in the U.S., and until recently, was mainly engaged in business in Japan. Recently, management determined that it was in the Company's best interest to enter the larger U.S. medical equipment market and take advantage of its relationships. Exlites business model is unique in that the Company strives to provide assistance and resources to certain medical equipment manufacturers, many of whom are overseas, are more cost effective and may require FDA approval. By partnering with these medical equipment companies, Exlites can obtain better pricing for the best quality products for its customers. Exlites' business plan includes assisting manufacturers to obtain FDA registration and approval.

SALT LAKE CITY, UT--(Marketwired - Aug 12, 2013) - Exlites Holdings International, Inc. (PINKSHEETS: EXHI) announced that it has entered into an agreement with a company that will source new cutting edge medical products from China, Taiwan and Japan. Exlites has contracted with a company in Utah whose mission is to assist medical product companies from around the world to develop economic opportunities and exclusive vendor arrangements with U.S. corporations.

Exlites has been developing a division specifically to assist companies in China, Taiwan and Japan to obtain FDA approval for their products as well as financing to bring those products to the U.S. market. Hang Yee, Managing Director of the consulting firm, stated that "The agreement should yield new exclusive vendor relationships with medical product companies in China and Japan and will allow Exlites to enter new markets to provide customers with medical equipment that contains cutting-edge technology," said Ms. Yee. "Companies throughout China, Taiwan and Japan are developing new medical equipment everyday and we have exclusive relationships with many of those companies from whom Exlites may derive significant economic benefit by selling their products here in the U.S.," she added.

Exlites' Director of Operations U.S., Michael Williams, agreed that the new agreement with the consulting firm should bring significant new exclusive vendor arrangements and products to Exlites. "The consulting firm has been developing meaningful relationships with corporations in China, Taiwan and Japan for a very long time," he said. "Entering into this agreement will allow us to leverage those relationships to benefit Exlites by bringing new products with cutting-edge technology that can be sold exclusively by Exlites."
Exlites was incorporated in the U.S., and until recently, was mainly engaged in business in Japan. Recently, management determined that it was in the Company's best interest to enter the larger U.S. medical equipment market and take advantage of its relationships. Exlites business model is unique in that the Company strives to provide assistance and resources to certain medical equipment manufacturers, many of whom are overseas, are more cost effective and may require FDA approval. By partnering with these medical equipment companies, Exlites can obtain better pricing for the best quality products for its customers. Exlites' business plan includes assisting manufacturers to obtain FDA registration and approval.

Salt Lake City, UT - 8/8/2013 7:00:00 AM - Exlites Holdings International, Inc. (OTC PINK: EXHI) is hard at work to make sure it brings the most cutting edge technology to its customers. The Company is developing a division specifically to assist companies in the U.S., China, and others, to obtain FDA approval for their products as well as financing to bring those products to the U.S. market.

Exlites' management says that manufacturers in the U.S. and China are developing a new piece of medical equipment every day. However, Exlites management has found that many of those companies do not have the ability to efficiently gain FDA approval or they may lack sufficient resources to bring the medical equipment to a large market like the U.S. or China and enter that market effectively. Exlites believes that by providing the right resources to these companies it will be able to partner with them and provide customers access to some of the most cutting edge medical equipment that is being developed today.

The Company's Director of Operations U.S., Michael Williams, stated that a company invents a new piece of medical equipment or a medical device every day, so the development of new supplies seems to grow exponentially every year," said Williams. "Of course our main goal is to sell medical equipment, however, having the first access to cutting edge medical equipment is important," Williams added.

Exlites was incorporated in the U.S., and until recently, was mainly engaged in business in Japan. Recently, management determined that it was in the Company's best interest to enter the larger U.S. medical equipment market and take advantage of its relationships. Exlites business model is unique in that the Company strives to provide assistance and resources to certain medical equipment manufacturers, many of whom are overseas, are more cost effective and may require FDA approval. By partnering with these medical equipment companies, Exlites can obtain better pricing for the best quality products for its customers. Exlites' business plan includes assisting manufacturers to obtain FDA registration and approval.

Salt Lake City, July 31, 2013(eTeligis via ACCESSWIRE) -- Exlites Holdings International, Inc. (EXHI) has entered the U.S. medical equipment market and plans to offer equipment that uses cutting edge, cost effective technology to its customers. The company was incorporated in the U.S., and until recently, was mainly engaged in business in Japan. Recently, management determined that it was in the Company’s best interest to enter the larger U.S. medical equipment market and take advantage of its relationships.

The Company’s Director of Operations U.S., Michael Williams, stated that Exlites will leverage its relationships with product manufacturers to provide cost efficient cutting edge medical equipment to customers in the U.S. “Exlites has relationships with manufacturers that develop and produce products that are more cost effective to hospitals, assisted living facilities and private individual customers”, said Williams adding that “the company is a natural fit for the expanding U.S. medical equipment market,”. According to Espicom’s medical market research report, The U.S. market is one of the largest in the world. “At an estimated USD$120.4 billion in 2012, the US medical device market is the world's largest market. Per capita expenditure, [is] at USD$381, [and] is the second highest in the world.”

Exlites business model is unique in that the Company strives to provide assistance and resources to certain medical equipment manufacturers, many of whom are overseas, are more cost effective and may require FDA approval. By partnering with these medical equipment companies, Exlites can obtain better pricing for the best quality products for its customers. Exlites’ business plan includes assisting manufacturers to obtain FDA registration and approval.

Espicom: “The Medica Device Market: USA”.
About Exlites Holdings International Inc. Exlites Holdings International Inc. was operated in Japan for a number of years before moving to the United States. The Company’s products are sold online and through the company's affiliate and distribution programs. The Company is dedicated to offering medical equipment to hospitals, assisted living facilities and to private individuals who seek quality medical equipment at cost effective prices. The Company’s website is at http://www.exlitesmedical.com.

HENDERSON, Nev., March 1, 2013 /PRNewswire/ -- Trulan Resources Inc. (TLAN) (the "Company" or "Trulan") reports that, following an economic review of the recently acquired IGP Project in Chile, there are two acknowledged sources of revenue that can be realized from the Project. Each of the four ore bodies on the acquired property contain a host of various mineralization that can be described as either heavy mineral components, or light mineral components.

Extraction and processing of the ore is considered to be straightforward in nature and requires the construction of technologically specific but well understood equipment. Updated budgets and sourcing of the components required in the construction of a mining and processing facility are being formulated from existing models. There is little to no over-burden on the deposits such as soil, forest, or grass cover and the recovery technology to be used is environmentally friendly and reclamation costs are minimal. The deposits are also easily and readily accessible by the Pan-American Freeway and local road infrastructure.

A third source of potential revenue is expected from the bedrock that underlies the deposits. This bedrock has never been tested or drilled. The basement rocks of the underlying formation are also considered to be a primary source of mineralization and there are indications of very good potential at depth.

Trulan intends to develop an exploration work program to test the IGP bedrock and plans to begin this work as soon as possible. The development plan and construction of the processing facility is a primary focus and the Company expects to have an engineering report within the second quarter.

Trulan Resource's Mission is the exploration and development of mining properties whose economic potential is considered to be extensive, while requiring minimal infrastructure and operational costs, that can be advanced in an environmentally responsible manner.

This news release was prepared on behalf of the Board of Directors, which accepts full responsibility for its contents. For more information please contact Corporate Relations at 702-430-4690 or info@trulanresources.com
Robert Rosner
President & CEO